{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T10:06:30Z","timestamp":1788516390668,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81173631"],"award-info":[{"award-number":["81173631"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.bcp.2015.01.004","type":"journal-article","created":{"date-parts":[[2015,1,17]],"date-time":"2015-01-17T00:45:13Z","timestamp":1421455513000},"page":"30-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Intestinal interleukin-10 mobilization as a contributor to the anti-arthritis effect of orally administered madecassoside: A unique action mode of saponin compounds with poor bioavailability"],"prefix":"10.1016","volume":"94","author":[{"given":"Ting","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifeng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannong","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyi","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2015.01.004_bib0240","doi-asserted-by":"crossref","first-page":"526","DOI":"10.2174\/138920007781368863","article-title":"Metabolic activation of herbal and dietary constituents and its clinical and toxicological implications: an update","volume":"8","author":"Zhou","year":"2007","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.bcp.2015.01.004_bib0245","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1007\/s11606-008-0632-y","article-title":"Herbal medicine in the United States: review of efficacy, safety, and regulation: grand rounds at University of California, San Francisco Medical Center","volume":"23","author":"Bent","year":"2008","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.bcp.2015.01.004_bib0250","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.2174\/092986710793205336","article-title":"Disposition pathways and pharmacokinetics of herbal medicines in humans","volume":"17","author":"He","year":"2010","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bcp.2015.01.004_bib0255","doi-asserted-by":"crossref","first-page":"558","DOI":"10.2174\/1389200211209050558","article-title":"Pharmacokinetics\u2013pharmacology disconnection of herbal medicines and its potential solutions with cellular pharmacokinetic\u2013pharmacodynamic strategy","volume":"13","author":"Zhang","year":"2012","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.bcp.2015.01.004_bib0260","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.2174\/138945012804545498","article-title":"Bioavailability challenges associated with development of saponins as therapeutic and chemopreventive agents","volume":"13","author":"Gao","year":"2012","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.bcp.2015.01.004_bib0265","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1742-2094-8-100","article-title":"Peripheral anti-inflammatory effects explain the ginsenosides paradox between poor brain distribution and anti-depression efficacy","volume":"8","author":"Kang","year":"2011","journal-title":"J Neuroinflamm"},{"key":"10.1016\/j.bcp.2015.01.004_bib0270","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1677\/JOE-08-0419","article-title":"Berberine promotes glucagon-like peptide-1 (7-36) amide secretion in streptozotocin-induced diabetic rats","volume":"200","author":"Lu","year":"2009","journal-title":"J Endocrinol"},{"key":"10.1016\/j.bcp.2015.01.004_bib0275","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bcp.2015.01.004_bib0280","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","article-title":"Rheumatoid arthritis","volume":"376","author":"Scott","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2015.01.004_bib0285","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.rdc.2010.11.004","article-title":"Herbal medicine in the treatment of rheumatic diseases","volume":"37","author":"Ernst","year":"2011","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.bcp.2015.01.004_bib0290","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.intimp.2007.05.006","article-title":"Anti-arthritic effect of ginsenoside Rb1 on collagen induced arthritis in mice","volume":"7","author":"Kim","year":"2007","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.bcp.2015.01.004_bib0295","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1248\/bpb.29.967","article-title":"The anti-gastropathic and anti-rheumatic effect of niga-ichigoside F1 and 23-hydroxytormentic acid isolated from the unripe fruits of Rubus coreanus in a rat model","volume":"29","author":"Nam","year":"2006","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.bcp.2015.01.004_bib0300","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.intimp.2008.06.011","article-title":"Anti-rheumatoid arthritic effect of madecassoside on type II collagen-induced arthritis in mice","volume":"8","author":"Liu","year":"2008","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.bcp.2015.01.004_bib0305","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.phymed.2008.11.002","article-title":"Madecassoside attenuates inflammatory response on collagen-induced arthritis in DBA\/1 mice","volume":"16","author":"Li","year":"2009","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bcp.2015.01.004_bib0310","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1055\/s-0029-1186142","article-title":"Anti-inflammatory effects of madecassic acid via the suppression of NF-kappaB pathway in LPS-induced RAW 264. 7 macrophage cells","volume":"76","author":"Won","year":"2010","journal-title":"Planta Med"},{"key":"10.1016\/j.bcp.2015.01.004_bib0315","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/bmc.1620","article-title":"Development and validation of high-performance liquid chromatography\/electrospray ionization mass spectrometry for assay of madecassoside in rat plasma and its application to pharmacokinetic study","volume":"26","author":"Han","year":"2012","journal-title":"Biomed Chromatogr"},{"key":"10.1016\/j.bcp.2015.01.004_bib0320","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1080\/0049825021000017920","article-title":"Differences in pharmacokinetics and hepatobiliary transport of a novel anti-inflammatory agent between normal and adjuvant arthritis rats","volume":"32","author":"Achira","year":"2002","journal-title":"Xenobiotica"},{"key":"10.1016\/j.bcp.2015.01.004_bib0325","doi-asserted-by":"crossref","first-page":"7697","DOI":"10.1021\/jf302529x","article-title":"Bioavailability, distribution, and antioxidative effects of selected triterpenes in mice","volume":"60","author":"Yin","year":"2012","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.bcp.2015.01.004_bib0330","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.immuni.2010.06.001","article-title":"Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells","volume":"32","author":"Wu","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2015.01.004_bib0335","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1600-065X.2011.01017.x","article-title":"Oral tolerance","volume":"241","author":"Weiner","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.bcp.2015.01.004_bib0340","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.4049\/jimmunol.166.7.4650","article-title":"Human leukocyte subpopulations from inflamed gut bind to joint vasculature using distinct sets of adhesion molecules","volume":"166","author":"Salmi","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.bcp.2015.01.004_bib0345","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1136\/ard.51.1.126","article-title":"Adhesion of rheumatoid peripheral blood and synovial fluid mononuclear cells to high endothelial venules of gut mucosa","volume":"51","author":"Kadioglu","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.bcp.2015.01.004_bib0350","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/mi.2012.71","article-title":"Prevention of type 1 diabetes through infection with an intestinal nematode parasite requires IL-10 in the absence of a Th2-type response","volume":"6","author":"Mishra","year":"2013","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.bcp.2015.01.004_bib0355","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.3748\/wjg.15.2469","article-title":"Combined therapeutic approach: inflammatory bowel diseases and peripheral or axial arthritis","volume":"15","author":"Atzeni","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bcp.2015.01.004_bib0360","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1084\/jem.20070906","article-title":"Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases","volume":"205","author":"Armaka","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.bcp.2015.01.004_bib0365","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0090-1229(88)90008-6","article-title":"Immunosuppressive effect of FK506 on collagen-induced arthritis in rats","volume":"46","author":"Inamura","year":"1988","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.bcp.2015.01.004_bib0370","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/art.1780330512","article-title":"Homologous type II collagen-induced arthritis in rats. Characterization of the disease and demonstration of clinically distinct forms of arthritis in two strains of rats after immunization with the same collagen preparation","volume":"33","author":"Larsson","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bcp.2015.01.004_bib0375","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0002-9440(10)63991-0","article-title":"Dynamics of early synovial cytokine expression in rodent collagen-induced arthritis: a therapeutic study using a macrophage-deactivating compound","volume":"158","author":"Palmblad","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bcp.2015.01.004_bib0380","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1742-2094-8-29","article-title":"Temporal profiles of age-dependent changes in cytokine mRNA expression and glial cell activation after status epilepticus in postnatal rat hippocampus","volume":"8","author":"J\u00e4rvel\u00e4","year":"2011","journal-title":"J Neuroinflamm"},{"key":"10.1016\/j.bcp.2015.01.004_bib0385","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.3945\/jn.109.118448","article-title":"Bovine glycomacropeptide has intestinal antiinflammatory effects in rats with dextran sulfate-induced colitis","volume":"140","author":"L\u00f3pez-Posadas","year":"2010","journal-title":"J Nutr"},{"key":"10.1016\/j.bcp.2015.01.004_bib0390","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jhep.2013.06.016","article-title":"Possible involvement of CCL1-CCR8 interaction in lymphocytic recruitment in IgG4-related sclerosing cholangitis","volume":"59","author":"Zen","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.bcp.2015.01.004_bib0395","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJM200103223441207","article-title":"Cytokine pathways and joint inflammation in rheumatoid arthritis","volume":"344","author":"Choy","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bcp.2015.01.004_bib0400","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1136\/ard.2010.134684","article-title":"State-of-the-art: rheumatoid arthritis","volume":"69","author":"McInnes","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.bcp.2015.01.004_bib0405","first-page":"827","article-title":"A LC-ESI-MS method for the simultaneous determination of madecassoside and its metabolite madecassic acid in rat plasma: application to comparison e pharmacokinetics in normal and collagen-induced arthritics rats","volume":"12","author":"Wang","year":"2014","journal-title":"Chin J Nat Med"},{"key":"10.1016\/j.bcp.2015.01.004_bib0410","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.immuni.2009.08.011","article-title":"Regulatory T cells reinforce intestinal homeostasis","volume":"31","author":"Barnes","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2015.01.004_bib0415","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1023\/A:1011907920641","article-title":"Modeling of pharmacokinetic\/pharmacodynamic (PK\/PD) relationships: concepts and perspectives","volume":"16","author":"Derendorf","year":"1999","journal-title":"Pharm Res"},{"key":"10.1016\/j.bcp.2015.01.004_bib0420","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrd1109","article-title":"Therapeutic strategies for rheumatoid arthritis","volume":"2","author":"Smolen","year":"2003","journal-title":"Nat Rev Drug Discovery"},{"key":"10.1016\/j.bcp.2015.01.004_bib0425","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(07)60784-3","article-title":"New therapies for treatment of rheumatoid arthritis","volume":"370","author":"Smolen","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2015.01.004_bib0430","doi-asserted-by":"crossref","first-page":"R212","DOI":"10.1186\/ar3545","article-title":"IL-10 signaling in CD4+ T cells is critical for the pathogenesis of collagen-induced arthritis","volume":"13","author":"Tao","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.bcp.2015.01.004_bib0435","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1002\/eji.200940294","article-title":"Understanding the molecular mechanisms of the multifaceted IL-10-mediated anti-inflammatory response: lessons from neutrophils","volume":"40","author":"Bazzoni","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.bcp.2015.01.004_bib0440","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.4049\/jimmunol.147.11.3815","article-title":"IL-10 inhibits cytokine production by activated macrophages","volume":"147","author":"Fiorentino","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.bcp.2015.01.004_bib0445","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/j.ajpath.2012.03.010","article-title":"IL-10-producing regulatory B10 cells ameliorate collagen-induced arthritis via suppressing Th17 cell generation","volume":"180","author":"Yang","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bcp.2015.01.004_bib0450","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2011.03.018","article-title":"Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation","volume":"34","author":"Chaudhry","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2015.01.004_bib0455","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/annrheumdis-2011-200003","article-title":"Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration","volume":"71","author":"Chatzidionysiou","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.bcp.2015.01.004_bib0460","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/art.37849","article-title":"Interleukin-22 reduces the severity of collagen-induced arthritis in association with increased levels of interleukin-10","volume":"65","author":"Sarkar","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bcp.2015.01.004_bib0465","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ijpara.2008.08.007","article-title":"Schistosoma mansoni infection reduces severity of collagen-induced arthritis via down-regulation of pro-inflammatory mediators","volume":"39","author":"Osada","year":"2009","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.bcp.2015.01.004_bib0470","doi-asserted-by":"crossref","first-page":"e49731","DOI":"10.1371\/journal.pone.0049731","article-title":"Disease-dependent local IL-10 production ameliorates collagen induced arthritis in mice","volume":"7","author":"Henningsson","year":"2012","journal-title":"PLoS ONE"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295215000532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295215000532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T02:01:15Z","timestamp":1690855275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295215000532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0006295215000532"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2015.01.004","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intestinal interleukin-10 mobilization as a contributor to the anti-arthritis effect of orally administered madecassoside: A unique action mode of saponin compounds with poor bioavailability","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2015.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}